0001635088 2025-04-01 2026-03-31 0001635088 2024-04-01 2025-03-31 0001635088 2023-04-01 2024-03-31 0001635088 2022-04-01 2023-03-31 0001635088 ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember ecd:PeoMember 2025-04-01 2026-03-31 0001635088 ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember ecd:NonPeoNeoMember 2025-04-01 2026-03-31 0001635088 ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember ecd:PeoMember 2025-04-01 2026-03-31 0001635088 ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember ecd:NonPeoNeoMember 2025-04-01 2026-03-31 0001635088 ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember ecd:PeoMember 2025-04-01 2026-03-31 0001635088 ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember ecd:NonPeoNeoMember 2025-04-01 2026-03-31 0001635088 ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember ecd:PeoMember 2025-04-01 2026-03-31 0001635088 ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember ecd:NonPeoNeoMember 2025-04-01 2026-03-31 0001635088 ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember ecd:PeoMember 2025-04-01 2026-03-31 0001635088 ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember ecd:NonPeoNeoMember 2025-04-01 2026-03-31 0001635088 2026-03-31 0001635088 2025-03-31 0001635088 2024-03-28 0001635088 2023-03-31 0001635088 2022-03-31 0001635088 1 2025-04-01 2026-03-31 iso4217:USD iso4217:USD shares Roivant Sciences Ltd. <div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">Equity Granting Practices<span style="font-style: normal; font-weight: normal;"> </span></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Although we do not have a formal policy with respect to the timing of grants of our incentive equity awards, the Compensation Committee has historically granted such awards on a predetermined annual schedule during the first quarter of our fiscal year. We also periodically grant off-cycle incentive equity awards in connection with specific circumstances such as new hires, promotions, special incentive or retention efforts or as replacement grants. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company has never granted, and has no plans to grant, any equity award to current or new employees in anticipation of the release of material nonpublic information, and we do not accelerate or delay the release of material nonpublic information based on equity award grant dates or for the purpose of affecting the value of executive compensation. The exercise price of stock options is no less than the closing price of our stock on the effective date of the grant. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Although we do not have a formal policy with respect to the timing of grants of our incentive equity awards, the Compensation Committee has historically granted such awards on a predetermined annual schedule during the first quarter of our fiscal year. We also periodically grant off-cycle incentive equity awards in connection with specific circumstances such as new hires, promotions, special incentive or retention efforts or as replacement grants. </div> true <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company has never granted, and has no plans to grant, any equity award to current or new employees in anticipation of the release of material nonpublic information, and we do not accelerate or delay the release of material nonpublic information based on equity award grant dates or for the purpose of affecting the value of executive compensation. The exercise price of stock options is no less than the closing price of our stock on the effective date of the grant. </div> false false true <div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">Pay Versus Performance </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We are required by SEC rules to disclose the following information regarding compensation paid to our Principal Executive Officer (the “PEO”) and our other NEOs (collectively, the “Non-PEO NEOs”). The amounts set forth below under the headings “Compensation Actually Paid to PEO” and “Average Compensation Actually Paid to Non-PEO NEOs” have been calculated in a manner prescribed by the SEC rules and do not necessarily align with how we or the Compensation Committee view the link between our performance and the pay of our NEOs. </div><table cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto; border-spacing: 0px;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 60pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 50.59pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 50.59pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 50.38pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 50.59pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td colspan="4" style="height: 6pt; width: 90.2pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 46.33pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 25.3pt;"><div style="font-size: 1pt;"> </div></td></tr><tr class="BRDSX_header"><td rowspan="2" style="width: 60pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Year⁽¹⁾<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">(a)</div></td><td rowspan="2" style="width: 3.14pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td rowspan="2" style="width: 3.14pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td rowspan="2" style="width: 50.59pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Summary<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Compensation<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Table Total for<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">PEO⁽²⁾<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(b)</div></td><td rowspan="2" style="width: 3.14pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td rowspan="2" style="width: 3.14pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td rowspan="2" style="width: 50.59pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Compensation<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Actually Paid<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">to PEO⁽³⁾<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(c)</div></td><td rowspan="2" style="width: 3.14pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td rowspan="2" style="width: 3.14pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td rowspan="2" style="width: 50.38pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Summary<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Compensation<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Table Total for<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Non-PEO<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">NEOs⁽²⁾<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(d)</div></td><td rowspan="2" style="width: 3.14pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td rowspan="2" style="width: 3.14pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td rowspan="2" style="width: 50.59pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Compensation<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Actually Paid<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">to Non-PEO<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">NEOs⁽³⁾<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(e)</div></td><td rowspan="2" style="width: 3.14pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td colspan="4" style="width: 90.2pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value of Initial Fixed $100 <br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Investment Based On:</div></td><td style="width: 3.14pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td rowspan="2" style="width: 3.14pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td rowspan="2" style="width: 46.33pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Net (Loss) <br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Income <br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($ Millions)⁽⁶⁾<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(h)</div></td><td rowspan="2" style="width: 3.14pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td rowspan="2" style="width: 3.14pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td rowspan="2" style="width: 25.3pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Share <br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price <br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($)⁽⁷⁾<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(i) </div></td></tr><tr class="BRDSX_header"><td style="width: 3.14pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td style="width: 44.24pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Roivant <br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">TSR⁽⁴⁾<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(f)</div></td><td style="width: 3.14pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td style="width: 39.68pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Peer <br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Group <br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">TSR⁽⁵⁾<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(g) </div></td><td style="width: 3.14pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td></tr><tr><td style="width: 60pt; padding-top: 2.04pt; padding-bottom: 1.53pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Fiscal 2025</div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 50.59pt; padding-top: 2.04pt; padding-bottom: 1.53pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<span style="padding-left: 9.2pt;">3,096,190</span></div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 50.59pt; padding-top: 2.04pt; padding-bottom: 1.53pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$382,436,735</div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 50.38pt; padding-top: 2.04pt; padding-bottom: 1.53pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 2.19pt; text-align: left;">$38,292,008</div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 50.59pt; padding-top: 2.04pt; padding-bottom: 1.53pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$230,820,261</div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 44.24pt; padding-top: 2.04pt; padding-bottom: 1.53pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 12.93pt; text-align: left;">$561</div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 39.68pt; padding-top: 2.04pt; padding-bottom: 1.53pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 10.65pt; text-align: left;">$145</div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 46.33pt; padding-top: 2.04pt; padding-bottom: 1.53pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 5.71pt; text-align: left;">$<span style="padding-left: 6.56pt;">(397.9)</span></div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 25.3pt; padding-top: 2.04pt; padding-bottom: 1.53pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$27.70 </div></td></tr><tr><td style="width: 60pt; padding-top: 1.19pt; padding-bottom: 1.53pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Fiscal 2024</div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 50.59pt; padding-top: 1.19pt; padding-bottom: 1.53pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$163,293,744</div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 50.59pt; padding-top: 1.19pt; padding-bottom: 1.53pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$120,292,276</div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 50.38pt; padding-top: 1.19pt; padding-bottom: 1.53pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 2.19pt; text-align: left;">$54,974,046</div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 50.59pt; padding-top: 1.19pt; padding-bottom: 1.53pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<span style="padding-left: 4.6pt;">43,159,484</span></div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 44.24pt; padding-top: 1.19pt; padding-bottom: 1.53pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 12.93pt; text-align: left;">$204</div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 39.68pt; padding-top: 1.19pt; padding-bottom: 1.53pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 10.65pt; text-align: left;">$104</div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 46.33pt; padding-top: 1.19pt; padding-bottom: 1.53pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 5.71pt; text-align: left;">$<span style="padding-left: 6.56pt;">(356.7)</span></div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 25.3pt; padding-top: 1.19pt; padding-bottom: 1.53pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$10.09 </div></td></tr><tr><td style="width: 60pt; padding-top: 1.19pt; padding-bottom: 1.53pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Fiscal 2023</div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 50.59pt; padding-top: 1.19pt; padding-bottom: 1.53pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<span style="padding-left: 16.1pt;">738,189</span></div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 50.59pt; padding-top: 1.19pt; padding-bottom: 1.53pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<span style="padding-left: 4.6pt;">45,536,504</span></div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 50.38pt; padding-top: 1.19pt; padding-bottom: 1.53pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 2.19pt; text-align: left;">$<span style="padding-left: 4.6pt;">4,740,297</span></div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 50.59pt; padding-top: 1.19pt; padding-bottom: 1.53pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<span style="padding-left: 9.2pt;">8,126,392</span></div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 44.24pt; padding-top: 1.19pt; padding-bottom: 1.53pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 12.93pt; text-align: left;">$213</div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 39.68pt; padding-top: 1.19pt; padding-bottom: 1.53pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 10.65pt; text-align: left;">$108</div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 46.33pt; padding-top: 1.19pt; padding-bottom: 1.53pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 5.71pt; text-align: left;">$<span style="padding-left: 2.72pt;">4,231.2</span></div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 25.3pt; padding-top: 1.19pt; padding-bottom: 1.53pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$10.54 </div></td></tr><tr><td style="width: 60pt; padding-top: 1.19pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Fiscal 2022</div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 50.59pt; padding-top: 1.19pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<span style="padding-left: 4.6pt;">48,978,825</span></div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 50.59pt; padding-top: 1.19pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<span style="padding-left: 4.6pt;">97,617,266</span></div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 50.38pt; padding-top: 1.19pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 2.19pt; text-align: left;">$48,706,774</div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 50.59pt; padding-top: 1.19pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<span style="padding-left: 4.6pt;">97,819,396</span></div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 44.24pt; padding-top: 1.19pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 12.93pt; text-align: left;">$149</div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 39.68pt; padding-top: 1.19pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 10.65pt; text-align: left;">$100</div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 46.33pt; padding-top: 1.19pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 5.71pt; text-align: left;">$(1,115.5)</div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 25.3pt; padding-top: 1.19pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<span style="padding-left: 4.6pt;">7.38</span></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 3.05pt; width: 60pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.05pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.05pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.05pt; width: 50.59pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.05pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.05pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.05pt; width: 50.59pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.05pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.05pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.05pt; width: 50.38pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.05pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.05pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.05pt; width: 50.59pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.05pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.05pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.05pt; width: 44.24pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.05pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.05pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.05pt; width: 39.68pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.05pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.05pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.05pt; width: 46.33pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.05pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.05pt; width: 3.14pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.05pt; width: 25.3pt;"><div style="font-size: 1pt;"> </div></td></tr></table><table border="0" cellpadding="0" style="margin-top: 3pt; margin-left: 0pt; border-spacing: 0px;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br/></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Matthew Gline, our Chief Executive Officer, was our PEO for each of the fiscal years presented. The individuals comprising the Non-PEO NEOs for each year presented are listed below. </div></td></tr></table><table cellpadding="0" class="BRDSX_txttab" style="width: 448pt; margin-left: 20pt; border-spacing: 0px;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 111pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 111pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 96pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 60.66pt;"><div style="font-size: 1pt;"> </div></td></tr><tr class="BRDSX_header"><td style="width: 111pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Fiscal 2025</div></td><td style="width: 11.56pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td style="width: 11.56pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td style="width: 111pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">Fiscal 2024</div></td><td style="width: 11.56pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td style="width: 11.56pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td style="width: 96pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">Fiscal 2023</div></td><td style="width: 11.56pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td style="width: 11.56pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td style="width: 60.66pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">Fiscal 2022 </div></td></tr><tr><td style="width: 111pt; padding-top: 2.08pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Richard Pulik<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Mayukh Sukhatme<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Eric Venker<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Frank Torti</div></td><td style="width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 111pt; padding-top: 2.08pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">Richard Pulik<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">Mayukh Sukhatme<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">Eric Venker<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">Jennifer Humes<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">Rakhi Kumar</div></td><td style="width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 96pt; padding-top: 2.08pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">Richard Pulik<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">Rakhi Kumar</div></td><td style="width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 60.66pt; padding-top: 2.08pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">Mayukh Sukhatme<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">Eric Venker</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 3.25pt; width: 111pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 111pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 96pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 60.66pt;"><div style="font-size: 1pt;"> </div></td></tr></table><table border="0" cellpadding="0" style="margin-top: 3pt; margin-left: 0pt; border-spacing: 0px;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br/></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">The dollar amounts reported in these columns represent the amount of total compensation reported for our PEO and on average for our Non-PEO NEOs for each covered fiscal year in the “Total” column of the Summary Compensation Table. </div></td></tr></table><table border="0" cellpadding="0" style="margin-top: 3pt; margin-left: 0pt; border-spacing: 0px;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br/></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">The applicable Summary Compensation Table totals reported for the PEO and the average of the Non-PEO NEOs for each year were subject to the following adjustments per Item 402(v)(2)(iii) of Regulation S-K to calculate “Compensation Actually Paid.” The equity award adjustments reflected in this reconciliation relate solely to equity awards denominated in the Company’s common shares and exclude equity awards denominated in shares of Immunovant common stock held by Dr. Venker and Dr. Torti, which were granted by the Immunovant Board or Compensation Committee in a separate, independent process, and which were not determined by the Roivant Board and Compensation Committee. For additional details regarding the pay versus performance disclosure of Immunovant, please refer to the Proxy Statement for Immunovant’s Annual Meeting of Shareholders filed with the SEC on July 22, 2026. </div></td></tr></table><table cellpadding="0" class="BRDSX_fintab" style="width: 448pt; margin-left: 20pt; border-spacing: 0px;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 317pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td colspan="4" style="height: 6pt; width: 116.89pt;"><div style="font-size: 1pt;"> </div></td></tr><tr class="BRDSX_header"><td style="width: 317pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td colspan="4" style="width: 116.89pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fiscal 2025 </div></td></tr><tr class="BRDSX_header"><td style="width: 317pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td style="width: 44pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">PEO</div></td><td style="width: 7.05pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td style="width: 58.79pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average for Non-<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">PEO NEOs </div></td></tr><tr><td style="width: 317pt; padding-top: 2.08pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Summary Compensation Table Total</div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 44pt; padding-top: 2.08pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<span style="padding-left: 8pt;">3,096,190</span></div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 58.79pt; padding-top: 2.08pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.4pt; text-align: left;">$<span style="padding-left: 4pt;">38,292,008 </span></div></td></tr><tr><td style="width: 317pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Adjustments<br/></div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 44pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 58.79pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"> </div></td></tr><tr><td style="width: 317pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">- Grant date fair value of Company equity awards granted during the covered fiscal year</div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 44pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 36pt;">—</span></div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 58.79pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.4pt; text-align: left;">$<span style="padding-left: 4pt;">28,509,818 </span></div></td></tr><tr><td style="width: 317pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">+ Fair value as of the end of the covered fiscal year of all Company equity awards granted during the covered fiscal year that are outstanding and unvested at the end of the covered fiscal year</div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 44pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 36pt;">—</span></div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 58.79pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.4pt; text-align: left;">$<span style="padding-left: 4pt;">93,195,873 </span></div></td></tr><tr><td style="width: 317pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">+/- Change in fair value as of the end of the covered fiscal year (from the end of the prior fiscal year) of any Company equity awards granted in any prior fiscal year that are outstanding and unvested as of the end of the covered fiscal year</div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 44pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$338,027,130</div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 58.79pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.4pt; text-align: left;">$<span style="padding-left: 4pt;">99,671,595 </span></div></td></tr><tr><td style="width: 317pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">+ Fair value as of the vesting date of any Company equity awards that were granted and vested in the covered fiscal year</div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 44pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 36pt;">—</span></div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 58.79pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.4pt; text-align: left;">$<span style="padding-left: 8pt;">2,543,622 </span></div></td></tr><tr><td style="width: 317pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">+/- Change in fair value as of the vesting date (from the end of the prior fiscal year) of any Company equity awards granted in any prior fiscal year for which all applicable vesting conditions were satisfied at the end of or during the covered fiscal year</div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 44pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<span style="padding-left: 4pt;">41,313,414</span></div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 58.79pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.4pt; text-align: left;">$<span style="padding-left: 4pt;">25,626,980 </span></div></td></tr><tr><td style="width: 317pt; padding-top: 1.33pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Compensation Actually Paid</div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 44pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$382,436,735</div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 58.79pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.4pt; text-align: left;">$230,820,261</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 3.25pt; width: 317pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 44pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 58.79pt;"><div style="font-size: 1pt;"> </div></td></tr></table><div class="BRDSX_ftnote" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-style: italic; margin-top: 4pt; margin-left: 20pt; text-align: left;">Note: Certain amounts may not sum due to rounding.</div><div class="BRDSX_ftnote" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-style: italic; margin-top: 3pt; margin-left: 20pt; text-align: left;">The fair values set forth in the table above are computed in accordance with Topic 718 as of the end of Fiscal 2025, other than fair values of awards that vest in the covered year, which are valued as of the applicable vesting date.<span style="font-style: normal;"> </span></div><table border="0" cellpadding="0" style="margin-top: 3pt; margin-left: 0pt; border-spacing: 0px;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(4)<br/></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Roivant TSR assumes $100 was invested at market close on March 31, 2022 and is calculated by dividing (i) the sum of the cumulative amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between our share price at market close at the end of the measurement period (March 31, 2026 for Fiscal 2025; March 31, 2025 for Fiscal 2024; March 28, 2024 for Fiscal 2023; and March 31, 2023 for Fiscal 2022) and our share price at market close at the beginning of the measurement period (March 31, 2022) by (ii) our share price at market close at the beginning of the measurement period (March 31, 2022). On March 31, 2026 </div></td></tr></table><div class="BRDSX_ftnote" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 5.25pt; margin-left: 20pt; text-align: left;">and 2025, March 28, 2024 and March 31, 2023 and 2022, the per share closing prices for our common shares were $27.70, $10.09, $10.54, $7.38 and $4.94, respectively. No dividends were paid for any periods presented. </div><table border="0" cellpadding="0" style="margin-top: 3pt; margin-left: 0pt; border-spacing: 0px;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(5)<br/></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">The Peer Group TSR set forth in this table utilizes the Nasdaq Biotechnology Index, which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2026. The comparison assumes $100 was invested for the period from March 31, 2022 to March 31, 2026. </div></td></tr></table><table border="0" cellpadding="0" style="margin-top: 3pt; margin-left: 0pt; border-spacing: 0px;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(6)<br/></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Reflects “Net (loss) income” in the Company’s Consolidated Statements of Operations included in the Company’s Annual Reports on Form 10-K for each of Fiscal 2025, Fiscal 2024, Fiscal 2023 and Fiscal 2022. </div></td></tr></table><table border="0" cellpadding="0" style="margin-top: 3pt; margin-left: 0pt; border-spacing: 0px;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(7)<br/></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Reflects the per share closing price for our common shares on each of March 31, 2026, March 31, 2025, March 28, 2024 and March 31, 2023. </div></td></tr></table> 3096190 382436735 38292008 230820261 561 145 -397900000 27.7 163293744 120292276 54974046 43159484 204 104 -356700000 10.09 738189 45536504 4740297 8126392 213 108 4231200000 10.54 48978825 97617266 48706774 97819396 149 100 -1115500000 7.38 <table border="0" cellpadding="0" style="margin-top: 3pt; margin-left: 0pt; border-spacing: 0px;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br/></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Matthew Gline, our Chief Executive Officer, was our PEO for each of the fiscal years presented. The individuals comprising the Non-PEO NEOs for each year presented are listed below. </div></td></tr></table><table cellpadding="0" class="BRDSX_txttab" style="width: 448pt; margin-left: 20pt; border-spacing: 0px;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 111pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 111pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 96pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 60.66pt;"><div style="font-size: 1pt;"> </div></td></tr><tr class="BRDSX_header"><td style="width: 111pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Fiscal 2025</div></td><td style="width: 11.56pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td style="width: 11.56pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td style="width: 111pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">Fiscal 2024</div></td><td style="width: 11.56pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td style="width: 11.56pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td style="width: 96pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">Fiscal 2023</div></td><td style="width: 11.56pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td style="width: 11.56pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td style="width: 60.66pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">Fiscal 2022 </div></td></tr><tr><td style="width: 111pt; padding-top: 2.08pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Richard Pulik<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Mayukh Sukhatme<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Eric Venker<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Frank Torti</div></td><td style="width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 111pt; padding-top: 2.08pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">Richard Pulik<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">Mayukh Sukhatme<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">Eric Venker<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">Jennifer Humes<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">Rakhi Kumar</div></td><td style="width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 96pt; padding-top: 2.08pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">Richard Pulik<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">Rakhi Kumar</div></td><td style="width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 60.66pt; padding-top: 2.08pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">Mayukh Sukhatme<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">Eric Venker</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 3.25pt; width: 111pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 111pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 96pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 11.56pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 60.66pt;"><div style="font-size: 1pt;"> </div></td></tr></table> Matthew Gline Matthew Gline Matthew Gline Matthew Gline <table border="0" cellpadding="0" style="margin-top: 3pt; margin-left: 0pt; border-spacing: 0px;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br/></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">The applicable Summary Compensation Table totals reported for the PEO and the average of the Non-PEO NEOs for each year were subject to the following adjustments per Item 402(v)(2)(iii) of Regulation S-K to calculate “Compensation Actually Paid.” The equity award adjustments reflected in this reconciliation relate solely to equity awards denominated in the Company’s common shares and exclude equity awards denominated in shares of Immunovant common stock held by Dr. Venker and Dr. Torti, which were granted by the Immunovant Board or Compensation Committee in a separate, independent process, and which were not determined by the Roivant Board and Compensation Committee. For additional details regarding the pay versus performance disclosure of Immunovant, please refer to the Proxy Statement for Immunovant’s Annual Meeting of Shareholders filed with the SEC on July 22, 2026. </div></td></tr></table><table cellpadding="0" class="BRDSX_fintab" style="width: 448pt; margin-left: 20pt; border-spacing: 0px;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 317pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td colspan="4" style="height: 6pt; width: 116.89pt;"><div style="font-size: 1pt;"> </div></td></tr><tr class="BRDSX_header"><td style="width: 317pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td colspan="4" style="width: 116.89pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fiscal 2025 </div></td></tr><tr class="BRDSX_header"><td style="width: 317pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td style="width: 44pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">PEO</div></td><td style="width: 7.05pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td style="width: 58.79pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average for Non-<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">PEO NEOs </div></td></tr><tr><td style="width: 317pt; padding-top: 2.08pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Summary Compensation Table Total</div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 44pt; padding-top: 2.08pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<span style="padding-left: 8pt;">3,096,190</span></div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 58.79pt; padding-top: 2.08pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.4pt; text-align: left;">$<span style="padding-left: 4pt;">38,292,008 </span></div></td></tr><tr><td style="width: 317pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Adjustments<br/></div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 44pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 58.79pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"> </div></td></tr><tr><td style="width: 317pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">- Grant date fair value of Company equity awards granted during the covered fiscal year</div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 44pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 36pt;">—</span></div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 58.79pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.4pt; text-align: left;">$<span style="padding-left: 4pt;">28,509,818 </span></div></td></tr><tr><td style="width: 317pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">+ Fair value as of the end of the covered fiscal year of all Company equity awards granted during the covered fiscal year that are outstanding and unvested at the end of the covered fiscal year</div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 44pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 36pt;">—</span></div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 58.79pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.4pt; text-align: left;">$<span style="padding-left: 4pt;">93,195,873 </span></div></td></tr><tr><td style="width: 317pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">+/- Change in fair value as of the end of the covered fiscal year (from the end of the prior fiscal year) of any Company equity awards granted in any prior fiscal year that are outstanding and unvested as of the end of the covered fiscal year</div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 44pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$338,027,130</div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 58.79pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.4pt; text-align: left;">$<span style="padding-left: 4pt;">99,671,595 </span></div></td></tr><tr><td style="width: 317pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">+ Fair value as of the vesting date of any Company equity awards that were granted and vested in the covered fiscal year</div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 44pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 36pt;">—</span></div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 58.79pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.4pt; text-align: left;">$<span style="padding-left: 8pt;">2,543,622 </span></div></td></tr><tr><td style="width: 317pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">+/- Change in fair value as of the vesting date (from the end of the prior fiscal year) of any Company equity awards granted in any prior fiscal year for which all applicable vesting conditions were satisfied at the end of or during the covered fiscal year</div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 44pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<span style="padding-left: 4pt;">41,313,414</span></div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 58.79pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.4pt; text-align: left;">$<span style="padding-left: 4pt;">25,626,980 </span></div></td></tr><tr><td style="width: 317pt; padding-top: 1.33pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Compensation Actually Paid</div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 44pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$382,436,735</div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 58.79pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.4pt; text-align: left;">$230,820,261</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 3.25pt; width: 317pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 44pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 58.79pt;"><div style="font-size: 1pt;"> </div></td></tr></table><div class="BRDSX_ftnote" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-style: italic; margin-top: 4pt; margin-left: 20pt; text-align: left;">Note: Certain amounts may not sum due to rounding.</div><div class="BRDSX_ftnote" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-style: italic; margin-top: 3pt; margin-left: 20pt; text-align: left;">The fair values set forth in the table above are computed in accordance with Topic 718 as of the end of Fiscal 2025, other than fair values of awards that vest in the covered year, which are valued as of the applicable vesting date.<span style="font-style: normal;"> </span></div> <table border="0" cellpadding="0" style="margin-top: 3pt; margin-left: 0pt; border-spacing: 0px;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br/></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">The applicable Summary Compensation Table totals reported for the PEO and the average of the Non-PEO NEOs for each year were subject to the following adjustments per Item 402(v)(2)(iii) of Regulation S-K to calculate “Compensation Actually Paid.” The equity award adjustments reflected in this reconciliation relate solely to equity awards denominated in the Company’s common shares and exclude equity awards denominated in shares of Immunovant common stock held by Dr. Venker and Dr. Torti, which were granted by the Immunovant Board or Compensation Committee in a separate, independent process, and which were not determined by the Roivant Board and Compensation Committee. For additional details regarding the pay versus performance disclosure of Immunovant, please refer to the Proxy Statement for Immunovant’s Annual Meeting of Shareholders filed with the SEC on July 22, 2026. </div></td></tr></table><table cellpadding="0" class="BRDSX_fintab" style="width: 448pt; margin-left: 20pt; border-spacing: 0px;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 317pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td colspan="4" style="height: 6pt; width: 116.89pt;"><div style="font-size: 1pt;"> </div></td></tr><tr class="BRDSX_header"><td style="width: 317pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td colspan="4" style="width: 116.89pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fiscal 2025 </div></td></tr><tr class="BRDSX_header"><td style="width: 317pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td style="width: 44pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">PEO</div></td><td style="width: 7.05pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; border-bottom: none;"><div style="font-size: 1pt;"> </div></td><td style="width: 58.79pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average for Non-<br/></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">PEO NEOs </div></td></tr><tr><td style="width: 317pt; padding-top: 2.08pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Summary Compensation Table Total</div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 44pt; padding-top: 2.08pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<span style="padding-left: 8pt;">3,096,190</span></div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 58.79pt; padding-top: 2.08pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.4pt; text-align: left;">$<span style="padding-left: 4pt;">38,292,008 </span></div></td></tr><tr><td style="width: 317pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Adjustments<br/></div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 44pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 58.79pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"> </div></td></tr><tr><td style="width: 317pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">- Grant date fair value of Company equity awards granted during the covered fiscal year</div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 44pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 36pt;">—</span></div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 58.79pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.4pt; text-align: left;">$<span style="padding-left: 4pt;">28,509,818 </span></div></td></tr><tr><td style="width: 317pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">+ Fair value as of the end of the covered fiscal year of all Company equity awards granted during the covered fiscal year that are outstanding and unvested at the end of the covered fiscal year</div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 44pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 36pt;">—</span></div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 58.79pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.4pt; text-align: left;">$<span style="padding-left: 4pt;">93,195,873 </span></div></td></tr><tr><td style="width: 317pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">+/- Change in fair value as of the end of the covered fiscal year (from the end of the prior fiscal year) of any Company equity awards granted in any prior fiscal year that are outstanding and unvested as of the end of the covered fiscal year</div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 44pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$338,027,130</div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 58.79pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.4pt; text-align: left;">$<span style="padding-left: 4pt;">99,671,595 </span></div></td></tr><tr><td style="width: 317pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">+ Fair value as of the vesting date of any Company equity awards that were granted and vested in the covered fiscal year</div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 44pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 36pt;">—</span></div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 58.79pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.4pt; text-align: left;">$<span style="padding-left: 8pt;">2,543,622 </span></div></td></tr><tr><td style="width: 317pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">+/- Change in fair value as of the vesting date (from the end of the prior fiscal year) of any Company equity awards granted in any prior fiscal year for which all applicable vesting conditions were satisfied at the end of or during the covered fiscal year</div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 44pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<span style="padding-left: 4pt;">41,313,414</span></div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;"> </div></td><td style="width: 58.79pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.4pt; text-align: left;">$<span style="padding-left: 4pt;">25,626,980 </span></div></td></tr><tr><td style="width: 317pt; padding-top: 1.33pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Compensation Actually Paid</div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 44pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$382,436,735</div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 58.79pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.4pt; text-align: left;">$230,820,261</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 3.25pt; width: 317pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 44pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 7.05pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 3.25pt; width: 58.79pt;"><div style="font-size: 1pt;"> </div></td></tr></table><div class="BRDSX_ftnote" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-style: italic; margin-top: 4pt; margin-left: 20pt; text-align: left;">Note: Certain amounts may not sum due to rounding.</div><div class="BRDSX_ftnote" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-style: italic; margin-top: 3pt; margin-left: 20pt; text-align: left;">The fair values set forth in the table above are computed in accordance with Topic 718 as of the end of Fiscal 2025, other than fair values of awards that vest in the covered year, which are valued as of the applicable vesting date.<span style="font-style: normal;"> </span></div> 3096190 38292008 0 -28509818 0 93195873 338027130 99671595 0 2543622 41313414 25626980 382436735 230820261 27.7 10.09 10.54 7.38 4.94 <table border="0" cellpadding="0" style="margin-top: 3pt; margin-left: 0pt; border-spacing: 0px;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(5)<br/></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">The Peer Group TSR set forth in this table utilizes the Nasdaq Biotechnology Index, which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2026. The comparison assumes $100 was invested for the period from March 31, 2022 to March 31, 2026. </div></td></tr></table> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">For Fiscal 2025, we did not use any financial performance measure to link “Compensation Actually Paid to PEO” or “Average Compensation Actually Paid to Non-PEO NEOs” to the Company’s performance, other than the Company’s share price, which was used as a performance vesting condition for the PSU awards granted to certain of our NEOs during Fiscal 2025, as described in more detail on page <a href="#tSECP">18</a> above. Specifically, certain share price hurdles are used as performance vesting conditions for these PSU awards. The Compensation Committee believes this metric is the most reflective of our value. For further information regarding our performance-based approach to executive compensation and how the Compensation Committee aligns executive compensation with the Company’s performance, see “Compensation Discussion and Analysis” above. </div><table cellpadding="0" class="BRDSX_txttab" style="width: 468pt; margin-left: auto; margin-right: auto; border-spacing: 0px;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 162pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 120pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 6pt; width: 162pt;"><div style="font-size: 1pt;"> </div></td></tr><tr><td style="width: 162pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> </div></td><td style="width: 6pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 6pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 120pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><span style="text-decoration:underline">Performance Measure</span></div></td><td style="width: 6pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 6pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 162pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> </div></td></tr><tr><td style="width: 162pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> </div></td><td style="width: 6pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 6pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 120pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Share price</div></td><td style="width: 6pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 6pt;"><div style="font-size: 1pt;"> </div></td><td style="width: 162pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> </div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 162pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 2.75pt; width: 120pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;"> </div></td><td style="height: 2.75pt; width: 162pt;"><div style="font-size: 1pt;"> </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Other than our share price, the Company does not use any other financial performance measures to link executive compensation actually paid to Company performance and, as permitted by the SEC rules, is not required to disclose any other measure as its most important financial performance measures. We utilize operational goals and objectives in our annual cash bonus program to link pay-with-performance. For details on such goals, see page <a href="#tOECP">17</a> above. </div> Share price Share price <div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Relationship Between PEO and Non-PEO NEO Compensation Actually Paid and Total Shareholder Return (“TSR”) </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our Non-PEO NEOs, Roivant TSR over the four most recently completed fiscal years and the Nasdaq Biotechnology Index TSR (our Peer Group TSR) over the same period.</div><img alt="" src="ny20073886x1_pvp01x1.jpg" style="height: 268px; width: 620px;"/> <div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Relationship Between PEO and Non-PEO NEO Compensation Actually Paid and Total Shareholder Return (“TSR”) </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our Non-PEO NEOs, Roivant TSR over the four most recently completed fiscal years and the Nasdaq Biotechnology Index TSR (our Peer Group TSR) over the same period.</div><img alt="" src="ny20073886x1_pvp01x1.jpg" style="height: 268px; width: 620px;"/> <div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Relationship Between PEO and Non-PEO NEO Compensation Actually Paid and Net (Loss) Income </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our Non-PEO NEOs and our Net Income (Loss) during the four most recently completed fiscal years. </div><img alt="" src="ny20073886x1_pvp02x1.jpg" style="height: 253px; width: 621px;"/> <div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Relationship Between PEO and Non-PEO NEO Compensation Actually Paid and Share Price </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our Non-PEO NEOs and the closing price of our common shares as reported by Nasdaq as of the last business day of each of Fiscal 2025, Fiscal 2024, Fiscal 2023 and Fiscal 2022. </div><img alt="" src="ny20073886x1_pvp03x1.jpg" style="height: 255px; width: 623px;"/> DEF 14A 0001635088 false